CAR-T therapeutics, a cutting-edge T-cell immunotherapy, have taken a front seat in the fight against cancer, accounting for over half of the approvals in the oncology cell and gene therapy arena. This innovative approach involves the genetic modification of autologous or allogeneic T-cells to express chimeric antigen receptors (CARs), enabling them to actively target and […]